AMVRX
Price
$16.40
Change
-$0.15 (-0.91%)
Updated
Oct 9 closing price
Net Assets
6.62B
JVMCX
Price
$28.02
Change
+$0.13 (+0.47%)
Updated
Oct 8 closing price
Net Assets
24.11B
Interact to see
Advertisement

AMVRX vs JVMCX

Header iconAMVRX vs JVMCX Comparison
Open Charts AMVRX vs JVMCXBanner chart's image
American Century Mid Cap Value R
Price$16.40
Change-$0.15 (-0.91%)
VolumeN/A
Net Assets6.62B
JHancock Disciplined Value Mid Cap C
Price$28.02
Change+$0.13 (+0.47%)
VolumeN/A
Net Assets24.11B
AMVRX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
AMVRX vs. JVMCX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMVRX is a Hold and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.1B vs. AMVRX (6.62B). AMVRX pays higher dividends than JVMCX: AMVRX (1.02) vs JVMCX (0.00). AMVRX was incepted earlier than JVMCX: AMVRX (20 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than AMVRX (1.47). AMVRX (50.00) and JVMCX (49.00) have comparable annual turnover. JVMCX has a lower initial minimum investment than AMVRX: JVMCX (1000) vs AMVRX (2500). AMVRX annual gain was more profitable for investors over the last year : -0.21 vs. JVMCX (-2.65). JVMCX return over 5 years is better than : 42.10 vs. AMVRX (13.63).
AMVRXJVMCXAMVRX / JVMCX
Total Expense Ratio1.471.8579%
Annual Report Gross Expense Ratio1.471.8679%
Fund Existence20 years14 years-
Gain YTD8.16410.23780%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets6.62B24.1B27%
Annual Yield % from dividends1.020.00-
Returns for 1 year-0.21-2.658%
Returns for 3 years16.6325.8264%
Returns for 5 years13.6342.1032%
Returns for 10 years12.8840.8132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX28.93N/A
N/A
Fidelity Select Pharmaceuticals Port
EAERX23.51N/A
N/A
Eaton Vance Stock A
GSFPX18.69N/A
N/A
Goldman Sachs US Eq Div and Premium P
RMDCX3.52-0.02
-0.56%
Virtus Silvant Mid-Cap Growth C
FESGX79.68-0.79
-0.98%
First Eagle Global C